Dalton, Greiner, Hartman, Maher & Co’s NCI, Inc. NCIT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-89,731
Closed -$1.89M 190
2017
Q2
$1.89M Sell
89,731
-33,172
-27% -$569K 0.11% 136
2017
Q1
$1.85M Sell
122,903
-73,877
-38% -$1.04M 0.11% 143
2016
Q4
$2.75M Buy
196,780
+6,488
+3% +$81.9K 0.16% 107
2016
Q3
$2.2M Buy
190,292
+115,330
+154% +$1.44M 0.14% 111
2016
Q2
$1.05M Buy
+74,962
New +$1.03M 0.07% 155
2015
Q2
Sell
-59,315
Closed -$613K 210
2015
Q1
$613K Sell
59,315
-80,543
-58% -$910K 0.03% 173
2014
Q4
$1.43M Buy
139,858
+2,318
+2% +$24.4K 0.08% 135
2014
Q3
$1.31M Buy
137,540
+10,458
+8% +$98K 0.07% 138
2014
Q2
$1.13M Buy
127,082
+23,612
+23% +$229K 0.06% 156
2014
Q1
$1.1M Buy
103,470
+67,535
+188% +$625K 0.06% 153
2013
Q4
$238K Buy
+35,935
New +$214K 0.01% 182

Dalton, Greiner, Hartman, Maher & Co's NCIT Position: Q3 2017 in Review

Dalton, Greiner, Hartman, Maher & Co sold out of NCI, Inc. (NCIT) in Q3 2017, closing a stake of 89,731 shares — an estimated $1.89M sold.

Dalton, Greiner, Hartman, Maher & Co first reported a position in NCIT in Q4 2013 and held it in 11 quarters. The position peaked at $2.75M in Q4 2016. 0 funds tracked by Wall St. Rank hold NCIT as of Q3 2017.

  • Dalton, Greiner, Hartman, Maher & Co reported no remaining NCI, Inc. position as of Q3 2017 after selling out during the quarter.
  • Dalton, Greiner, Hartman, Maher & Co sold 89,731 NCI, Inc. shares in Q3 2017, an estimated $1.89M.
  • Dalton, Greiner, Hartman, Maher & Co first reported a position in NCI, Inc. in Q4 2013 and held it in 11 quarters.
  • Dalton, Greiner, Hartman, Maher & Co's NCI, Inc. position peaked at $2.75M in Q4 2016.
  • 0 funds tracked by Wall St. Rank held NCI, Inc. as of Q3 2017.

Based on Dalton, Greiner, Hartman, Maher & Co's 13F filing for Q3 2017, filed 12 Oct 2017.